EUVIMEDEUVIMED entdecken
Open Access

Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model

Motokazu Sato, Kohei Mizuta, Qinghong Han, Sei Morinaga, Byung Mo Kang, Yutaro Kubota, Ryosuke Mori, Anton Baranov, Keita Kobayashi, Daniel Ardjmand, Noritoshi Kobayashi, Michael Bouvet und 3 weitere

In Vivo · 2024

DOI: 10.21873/invivo.13539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2024. Verfasst von Motokazu Sato und 14 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer Inc., San Diego, CA, U.S.A. Hauptthemen laut MEDLINE: Irinotecan, Methionine, Xenograft Model Antitumor Assays, Mice, Nude. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IrinotecanMethionineXenograft Model Antitumor AssaysMice, NudeColonic NeoplasmsCarbon-Sulfur LyasesAnimalsHumansMiceCamptothecinDisease Models, AnimalHCT116 CellsCell Line, TumorTumor Burden

Stichwörter der Autor:innen

Colon cancerHCT-116Hoffman effectcombination therapydose reductionirinotecanmethionine addictionmethionine restrictionnude micesynergy

Substanzen

IrinotecanMethionineCarbon-Sulfur LyasesL-methionine gamma-lyaseCamptothecin

Autor:innen und Institutionen

  • AntiCancer Inc., San Diego, CA, U.S.A.
  • Department of Surgery, University of California, San Diego, CA, U.S.A.
  • Department of Oncology, Yokohama City University School of Medicine, Yokohama, Japan.
  • Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Japan.
  • AntiCancer Inc., San Diego, CA, U.S.A.; all@anticancer.com.

Zitieren

APA

Sato, M., Mizuta, K., Han, Q., Morinaga, S., Kang, B. M., Kubota, Y., Mori, R., Baranov, A., Kobayashi, K., Ardjmand, D., Kobayashi, N., Bouvet, M., Ichikawa, Y., Nakajima, A., & Hoffman, R. M. (2024). Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model. In Vivo. https://doi.org/10.21873/invivo.13539

Vancouver

Sato M, Mizuta K, Han Q, Morinaga S, Kang BM, Kubota Y, et al. Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model. In Vivo. 2024. doi:10.21873/invivo.13539

BibTeX
@article{Sato2024,
  author = {Sato, Motokazu and Mizuta, Kohei and Han, Qinghong and Morinaga, Sei and Kang, Byung Mo and Kubota, Yutaro and Mori, Ryosuke and Baranov, Anton and Kobayashi, Keita and Ardjmand, Daniel and Kobayashi, Noritoshi and Bouvet, Michael and Ichikawa, Yasushi and Nakajima, Atsushi and Hoffman, Robert M},
  title = {Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model},
  journal = {In Vivo},
  year = {2024},
  doi = {10.21873/invivo.13539}
}
Kostenlos starten →